JNJ vs CI
By Alex · Tickerpine
Johnson & Johnson vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CI |
|---|---|---|
| Price | $285.75 | $297.00 |
| Market cap | $687.89B | $78.26B |
| P/E ratio | 43.4 | 13.1 |
| ROE | 20.02% | 15.65% |
| Profit margin | 16.20% | 2.09% |
| Revenue growth | 5.90% | 5.60% |
| Dividend yield | 1.88% | 2.10% |
| Beta | 0.20 | 0.25 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CI in plain English
- JNJ is the bigger company — about 8.8× the market cap of CI.
- CI is cheaper on earnings (P/E 13.1 vs 43.4).
- JNJ earns a higher return on equity (20% vs 16%).
- JNJ is growing revenue faster (6% vs 6%).
- CI has the higher dividend yield (2.10% vs 1.88%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.